Literature DB >> 8077507

Tinea capitis: epidemiology, diagnosis, treatment, and control.

I J Frieden1, R Howard.   

Abstract

Since the 1970s there has been a steady rise in the number of cases of tinea capitis in the United States, most of them caused by Trichophyton tonsurans. Although the infection is seen most frequently in black children, it can occur in white persons and can affect persons of all ages. Control of tinea capitis is difficult for several reasons, including subtle clinical infection, asymptomatic carriage of fungus, fomite spread, and the need for weeks to months of oral medications. Although griseofulvin remains the mainstay of therapy, preliminary studies of itraconazole and terbinafine suggest that these compounds may also be useful in the treatment of tinea capitis. Selenium sulfide shampoo, prednisone, and oral antibiotics are frequently used as adjunctive therapy. The role of fomites in the spread of tinea capitis has yet to be fully understood, as does the best means of decontamination.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8077507     DOI: 10.1016/s0190-9622(08)81266-2

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  9 in total

Review 1.  A risk-benefit assessment of the newer oral antifungal agents used to treat onychomycosis.

Authors:  A K Gupta; N H Shear
Journal:  Drug Saf       Date:  2000-01       Impact factor: 5.606

Review 2.  Terbinafine. An update of its use in superficial mycoses.

Authors:  K J McClellan; L R Wiseman; A Markham
Journal:  Drugs       Date:  1999-07       Impact factor: 9.546

Review 3.  National athletic trainers' association position statement: skin diseases.

Authors:  Steven M Zinder; Rodney S W Basler; Jack Foley; Chris Scarlata; David B Vasily
Journal:  J Athl Train       Date:  2010 Jul-Aug       Impact factor: 2.860

4.  Identification and genetic homogeneity of Trichophyton tonsurans isolated from several regions by random amplified polymorphic DNA.

Authors:  J A Kim; K Takizawa; K Fukushima; K Nishimura; M Miyaji
Journal:  Mycopathologia       Date:  1999       Impact factor: 2.574

Review 5.  Systemic antifungal agents.

Authors:  W Abuhammour; E Habte-Gabr
Journal:  Indian J Pediatr       Date:  2001-07       Impact factor: 1.967

Review 6.  Current and emerging azole antifungal agents.

Authors:  D J Sheehan; C A Hitchcock; C M Sibley
Journal:  Clin Microbiol Rev       Date:  1999-01       Impact factor: 26.132

7.  Safety and efficacy of terbinafine in a pediatric Iranian cohort of patients with Tinea capitis.

Authors:  Ali M Sabzghabaee; Parwin Mansouri; Mahboobeh Mohammadi
Journal:  Saudi Pharm J       Date:  2009-08-07       Impact factor: 4.330

8.  Multilocus genotyping identifies infections by multiple strains of Trichophyton tonsurans.

Authors:  Susan M Abdel-Rahman; Barry Preuett; Andrea Gaedigk
Journal:  J Clin Microbiol       Date:  2007-04-18       Impact factor: 5.948

9.  Prevalence of Tinea Capitis among School Children in Nok Community of Kaduna State, Nigeria.

Authors:  Josephine Dogo; Seniyat Larai Afegbua; Edward Christopher Dung
Journal:  J Pathog       Date:  2016-07-04
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.